IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Production of Prostaglandin $E_2$ and $I_2$ is Coupled with Cyclooxygenase-2 in Human Follicular Dendritic Cells

  • Cho, Wha-Jung (Department of Microbiology and Immunology, School of Medicine, Kangwon National University) ;
  • Kim, Jin-I (Department of Microbiology and Immunology, School of Medicine, Kangwon National University) ;
  • Cho, Kyu-Bong (Department of Clinical Laboratory Science, Shinheung College) ;
  • Choe, Jong-Seon (Department of Microbiology and Immunology, School of Medicine, Kangwon National University)
  • Received : 2011.10.05
  • Accepted : 2011.10.25
  • Published : 2011.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Prostaglandins (PGs) play pathogenic and protective roles in inflammatory diseases. The novel concept of PGs as immune modulators is being documented by several investigators. By establishing an in vitro experimental model containing human follicular dendritic cell-like cells, HK cells, we reported that HK cells produce prostaglandin $E_2$ ($PGE_2$) and prostaglandin $I_2$ ($PGI_2$) and that these PGs regulate biological functions of T and B cells. Methods: To investigate the respective contribution of cyclooxygenase-1 (COX-1) and COX-2 to $PGE_2$ and $PGI_2$ production in HK cells, we performed siRNA technology to knock down COX enzymes and examined the effect on PG production. Results: Both $PGE_2$ and $PGI_2$ productions were almost completely inhibited by the depletion of COX-2. In contrast, COX-1 knockdown did not significantly affect PG production induced by lipopolysaccharide (LPS). Conclusion: The current results suggest that mPGES-1 and PGIS are coupled with COX-2 but not with COX-1 in human follicular dendritic cell (FDC) and may help understand the potential effects of selective COX inhibitors on the humoral immunity.

Keywords

References

  1. Fosslien E: Cardiovascular complications of non-steroidal anti- inflammatory drugs. Ann Clin Lab Sci 35:347-385, 2005.
  2. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M: Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 338:70-76, 2005. https://doi.org/10.1016/j.bbrc.2005.08.152
  3. Nakashima K, Ueno N, Kamei D, Tanioka T, Nakatani Y, Murakami M, Kudo I: Coupling between cyclooxygenases and prostaglandin F(2alpha) synthase. Detection of an inducible, glutathione-activated, membrane-bound prostaglandin F(2alpha)-synthetic activity. Biochim Biophys Acta 1633: 96-105, 2003. https://doi.org/10.1016/S1388-1981(03)00092-1
  4. Chandrasekharan S, Foley NA, Jania L, Clark P, Audoly LP, Koller BH: Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland. J Lipid Res 46:2636-2648, 2005. https://doi.org/10.1194/jlr.M500213-JLR200
  5. Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA: Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest 116:1391-1399, 2006. https://doi.org/10.1172/JCI27540
  6. Vane J, Corin RE: Prostacyclin: a vascular mediator. Eur J Vasc Endovasc Surg 26:571-578, 2003. https://doi.org/10.1016/S1078-5884(03)00385-X
  7. Harizi H, Gualde N: The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens 65:507-514, 2005. https://doi.org/10.1111/j.1399-0039.2005.00394.x
  8. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP: Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150, 2002. https://doi.org/10.1016/S1471-4906(01)02154-8
  9. Rocca B, FitzGerald GA: Cyclooxygenases and prostaglandins: shaping up the immune response. Int Immunopharmacol 2:603-630.2002, https://doi.org/10.1016/S1567-5769(01)00204-1
  10. Sreeramkumar V, Fresno M, Cuesta N: Prostaglandin E(2) and T cells: friends or foes? Immunol Cell Biol 2011.
  11. Lee IY, Lee JH, Park WS, Nam EC, Shin YO, Choe JS: 3C8, a new monoclonal antibody directed against a follicular dendritic cell line, HK. Immune Netw 1:26-31, 2001. https://doi.org/10.4110/in.2001.1.1.26
  12. Lee IY, Ko EM, Kim SH, Jeoung DI, Choe J: Human follicular dendritic cells express prostacyclin synthase: a novel mechanism to control T cell numbers in the germinal center. J Immunol 175:1658-1664, 2005. https://doi.org/10.4049/jimmunol.175.3.1658
  13. Lee IY, Ko EM, Kim SH, Jeoung DI, Choe J: Human follicular dendritic cells express prostacyclin synthase: a novel mechanism to control T cell numbers in the germinal center. J Immunol 175:1658-1664, 2005. https://doi.org/10.4049/jimmunol.175.3.1658
  14. Lee IY, Cho W, Kim J, Park CS, Choe J: Human follicular dendritic cells interact with T cells via expression and regulation of cyclooxygenases and prostaglandin E and I synthases. J Immunol 180:1390-1397, 2008. https://doi.org/10.4049/jimmunol.180.3.1390
  15. Cho W, Kim Y, Jeoung DI, Kim YM, Choe J: IL-4 and IL-13 suppress prostaglandins production in human follicular dendritic cells by repressing COX-2 and mPGES-1 expression through JAK1 and STAT6. Mol Immunol 48:966-972, 2011 https://doi.org/10.1016/j.molimm.2011.01.007
  16. Kim J, Park CS, Park CH, Jeoung DI, Kim YM, Choe J: Beraprost enhances the APC function of B cells by upregulating CD86 expression levels. J Immunol 186: 3866-3873, 2011 https://doi.org/10.4049/jimmunol.1002170
  17. Kim HS, Zhang X, Choi YS: Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes. J Immunol 153:2951-2961, 1994
  18. Lee IY, Ha KS, Choe J: 3C8 antigen is a novel protein expressed by human follicular dendritic cells. Biochem Biophys Res Commun 303:624-630, 2003. https://doi.org/10.1016/S0006-291X(03)00384-X
  19. Bolego C, Buccellati C, Prada A, Gaion RM, Folco G, Sala A: Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone. FASEB J 23:605-612, 2009. https://doi.org/10.1096/fj.08-106591
  20. Spisni E, Bartolini G, Orlandi M, Belletti B, Santi S, Tomasi V: Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells. Exp Cell Res 219:507- 513, 1995. https://doi.org/10.1006/excr.1995.1259
  21. Fosbol EL, Kober L, Torp-Pedersen C, Gislason GH: Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals. Expert Opin Drug Saf 9:893-903, 2010. https://doi.org/10.1517/14740338.2010.501331

Cited by

  1. Follicular dendritic cells in health and disease vol.3, pp.None, 2011, https://doi.org/10.3389/fimmu.2012.00292
  2. Understanding the tumour micro‐environment communication network from an NOS2/COX2 perspective vol.176, pp.2, 2019, https://doi.org/10.1111/bph.14488